Key result
Testis ACE inactivation or ACE inhibitor treatment reduced ATP production in mouse sperm by 72% and impaired oxidative metabolism, motility, and fertilization capacity via PPARγ.
Why the study?
Testis angiotensin-converting enzyme plays a critical role in male fertility, but the underlying mechanism is unknown.
Does ACE inhibition impair sperm metabolism and fertilization capacity?
Does ACE inhibition impair sperm metabolism and fertilization capacity?
ACE inhibitors may impair male fertility by reducing sperm ATP production and oxidative metabolism via PPARγ downregulation.
ACEi may impair mouse sperm ATP and fertility; hypothesis-generating for human effects and should not change practice.
Testis angiotensin-converting enzyme (tACE) plays a critical role in male fertility, but the mechanism is unknown. By using ACE C-domain KO (CKO) mice which lack tACE activity, we found that ATP in CKO sperm was 9.4-fold lower than WT sperm. Similarly, an ACE inhibitor (ACEi) reduced ATP production in mouse sperm by 72%. Metabolic profiling showed that tACE inactivation severely affects oxidative metabolism with decreases in several Krebs cycle intermediates including citric acid, cis-aconitic acid, NAD, α-ketoglutaric acid, succinate, and L-malic acid. We found that sperms lacking tACE activity displayed lower levels of oxidative enzymes (CISY, ODO1, MDHM, QCR2, SDHA, FUMH, CPT2, and ATPA) leading to a decreased mitochondrial respiration rate. The reduced energy production in CKO sperms leads to defects in their physiological functions including motility, acrosine activity, and fertilization in vitro and in vivo. Male mice treated with ACEi show severe impairment in reproductive capacity when mated with female mice. In contrast, an angiotensin II receptor blocker (ARB) had no effect. CKO sperms express significantly less peroxisome proliferators-activated receptor gamma (PPARγ) transcription factor, and its blockade eliminates the functional differences between CKO and WT sperms, indicating PPARγ might mediate the effects of tACE on sperm metabolism. Finally, in a cohort of human volunteers, in vitro treatment with the ramipril or a PPARγ inhibitor reduced ATP production in human sperm and hence its motility and acrosine activity. These findings may have clinical significance since millions of people take ACEi daily, including men who are reproductively active.
No takes yet. Share an insight, caveat, or question.
Shibata et al. (2023) studied Male fertility and sperm metabolism. ACE inhibitor or tACE inactivation vs. Wild-type or untreated sperm was evaluated on ATP production and sperm physiological functions (motility, acrosine activity, fertilization). Testis ACE inactivation or ACE inhibitor treatment reduced ATP production in mouse sperm by 72% and impaired oxidative metabolism, motility, and fertilization capacity via PPARγ.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: